Polen Thomas E Jr sold (to issuer) $3.6M of BDX
Polen Thomas E Jr (Chairman, CEO and President) sold (to issuer) 17,246 shares of BECTON DICKINSON & CO (BDX) at $210.00 ($3.62M total) on 2026-11-05 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The insider transaction provides fresh data on insider sentiment; while not large enough to move the stock dramatically, it may influence short‑term trading.
Market read
Primary disclosure of an insider sale; modest relevance for traders monitoring insider activity.
What to watch
Potential upcoming capital allocation decisions or buyback plans that may offset the sell pressure.
Background
SEC Form 4 filing by Becton Dickinson & Co. CEO Polen Thomas E. Jr. reporting a 10b5‑1 planned sale of shares.
Ticker impact
Form 4 shows CEO sold 17,246 shares for $3.62M, reducing his stake to 113,156 shares.
likely downward pressure as market prices in the insider sell
The sale is sizable for an insider but not material to overall float; traders may watch for further insider activity.
Market effects
Minimal impact on the medical devices sector; the sale is company‑specific.
None
Low
Counterpoint
The sale could be a routine liquidity event unrelated to fundamentals.
Key entities
- ExecutivePolen Thomas E Jr
Chairman, CEO and President of Becton Dickinson & Co.
- CompanyBecton Dickinson & Co.
Medical technology and device manufacturer (ticker BDX).




